Stimate Nasal Spray National Drug Shortage

Published on
December 14, 2021

HHSC was made aware of a voluntary recall issued by Ferring Pharmaceuticals for all batches of their product, Stimate® (desmopressin acetate 1.5mg/ml) nasal spray. The U.S. Federal Drug Administration national drug shortage list currently lists these products, and the manufacturer estimates Stimate will not become available until the second half of 2023.

The Medicaid and Children's Health Insurance Program (CHIP) formularies include several alternative desmopressin products prescribing providers may consider for use in compounding given the ongoing shortage of Stimate. The national drug codes (NDCs) for Desmopressin are below, and Medicaid-enrolled prescribers may consider these for compounding a nasal spray with a valid prescription.

Drug name Strength NDC
DESMOPRESSIN VIAL 4 MCG/ML 00703505103
DESMOPRESSIN VIAL 4 MCG/ML 00703505401
DESMOPRESSIN VIAL 40 MCG/10 ML 16714001501
DESMOPRESSIN VIAL 4 MCG/ML 69918090110
DESMOPRESSIN AMPULE 4 MCG/ML 43598093109
DESMOPRESSIN AMPULE 4 MCG/ML 43598093111
DESMOPRESSIN AMPULE 4 MCG/ML 69918089910